Calliditas Therapeutics to Unveil Key Findings at Nephrology Congress Calliditas Therapeutics AB will showcase pivotal findings from the Phase 3 NefIgArd trial at the World Congress of Nephrology, shedding light on advances in IgA nephropathy treatment.

Calliditas Therapeutics to Unveil Key Findings at Nephrology Congress #Japan #Yokohama #Calliditas #TARPEYO #NefIgArd

Calliditas Therapeutics Showcases Groundbreaking Research at ASN Kidney Week 2025 Calliditas Therapeutics announces key data on IgAN and Alport Syndrome presented at the American Society of Nephrology Kidney Week, highlighting advancements in nephrology.

Calliditas Therapeutics Showcases Groundbreaking Research at ASN Kidney Week 2025 #USA #Houston #Calliditas #Alport_Syndrome #TARPEYO